Type
. Vaccination and skin test studies on the children of leprosy patients. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1989;57(1):38-44.
Type
. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1989;57(1):1-11.
Type
. Antagonism between dapsone and rifampicin in experimental Mycobacterium leprae infections in mice. Research in microbiology. 1989;140(2):143-50.
Type
. Study of multidrug therapy in paucibacillary leprosy. Journal of the Indian Medical Association. 1989;87(2):34-6.
Type
. Technical problems related to multidrug therapy in leprosy control. Acta leprologica. 1989;7(1):59-62.
Type
. [Immunologic aspects of leprosy]. Acta leprologica. 1989;7(1):37-40.
Type
. Leprosy associated mycobacteria: implications. Acta leprologica. 1989;7(1):1-6.
Type
. Immunotherapy for leprosy and tuberculosis. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques. 1989;33:415-48.
Type
. Evaluation of enzyme immunoassays using purified protein derivative (PPD) and its pooled fractions 3 and 4 for diagnosis of pulmonary tuberculosis. The Indian journal of chest diseases & allied sciences. 1989;31(1):25-32.
Type
. Vaccine development. On relating immunology to the Third World: some studies on leprosy. Immunology. Supplement. 1989;2:87-9; discussion 91-2.